DaVita
DVA
#2035
Rank
HK$78.34 B
Marketcap
HK$1,188
Share price
-2.25%
Change (1 day)
8.62%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): HK$78.92

According to DaVita's latest financial reports the company's current EPS (TTM) is HK$79.28. In 2024 the company made an earnings per share (EPS) of HK$86.41 an increase over its 2023 EPS that were of HK$59.62.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$78.92-8.67%
2024HK$86.4144.94%
2023HK$59.6227.26%
2022HK$46.85-35.56%
2021HK$72.7044.1%
2020HK$50.4519.7%
2019HK$42.15540.48%
2018HK$6.58-76.07%
2017HK$27.50-19.31%
2016HK$34.08242.52%
2015HK$9.95-62.87%
2014HK$26.7913.43%
2013HK$23.628.45%
2012HK$21.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
HK$183.87 131.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$82.50 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
HK$115.16 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$15.00-81.08%๐Ÿ‡บ๐Ÿ‡ธ USA